Commitments and Contingent Liabilities (Details) [Table] Future Gross Revenue [Member] Future Gross Revenue Member Method of Payment Royaltie [Axis] Method Of Payment Royaltie Axis Net Sales of All Company Product [Member] Net Sales Of All Company Product Member License Revenue to Jointly Developed Intellectual Property [Member] License Revenue To Jointly Developed Intellectual Property Member Revenue Generated from Patent [Member] Revenue Generated From Patent Member Israel Innovation Authority [Member] Israel Innovation Authority Member Ramot [Member] Ramot Member Royalty payment as a percentage of grants Royalty Payment As Percentage Of Grants The percentage at which royalty payments will be paid out on relative to the amount of grants received plus interest at LIBOR rate. Potential payment (in Dollars) Potential Payment The maximum potential amount of payment based on a agreement. Liabilities assumed (in Dollars) Liabilities Assumed Represent the total value of liabilities assumed. Installments payments (in Dollars) Installments Payments Amount of installments payments. Method of Payment Royaltie Domain [Domain] Net Sales of All Company Product Sold By Company Licenses [Member] Net Sales Of All Company Product Sold By Company Licenses Member License Revenue Related to Intellectual Property [Member] License Revenue Related To Intellectual Property Member Net Sales Squamous Cell Carcinoma [Member] Net Sales Squamous Cell Carcinoma Member Sales of Alpha Radiation Products [Member] Sales Of Alpha Radiation Products Member Statistical Measurement [Axis] Minimum [Member] Minimum [Member] Commitments and Contingent Liabilities [Line Items] Aggregate amount (in Dollars) Royalty Guarantees, Commitments, Amount Upfront payment (in Dollars) Upfront Payment Represent the amount of upfront payment. Shareholders’ Equity (Details) [Table] Share Purchase Agreement [Member] Purchase Agreement Member Total compensation cost Transaction Costs Amount of transaction costs. Ordinary Shares [Member] Ordinary shares Common Stock [Member] Number of warrant outstanding Class of Warrant or Right, Outstanding Increase to additional paid in capital in exchange for services Increase To Additional Paid In Capital In Exchange For Services Represent the amount of increase to additional paid in capital in exchange for services. Percentage of ordinary share premium Percentage of Ordinary Share Premium Percentage of ordinary share premium. Compensation expense Total share-based compensation expense Share-Based Payment Arrangement, Expense Purchase ordinary shares amount Amount of Purchase Ordinary Shares Value The amount of purchase ordinary shares value. Commitments and Contingent Liabilities [Abstract] Warrants exercise price Exercise price (in Dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Maximum [Member] Maximum [Member] Guarantee amount (in Dollars) Guarantees, Fair Value Disclosure Royalty rate Royalty Rate The percentage at which royalty payments will be paid out on. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Construction of Hudson NH Facility [Member] Construction Of Hudson NHFacility Member Number of warrant to purchase Warrants issued Class of Warrant or Right, Number of Securities Called by Warrants or Rights Shareholders’ Equity [Line Items] 2021 Share Incentive Plan [Member] Two Thousand Twenty One Share Incentive Plan Member Oramed [Member] Oramed Member Trading day volume weighted average price Trading Day Volume Weighted Average Price Number of trading day volume weighted average price. Sales of Product Containing Intellectual Property [Member] Sales Of Product Containing Intellectual Property Member Statistical Measurement [Domain] Schedule of Share Option Plan [Line Items] Shareholders’ Equity - Schedule of Share Option Plan (Details) [Line Items] Weighted average exercise price, Forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Schedule Of Rsus Under The Plan Abstract Award Type [Axis] Weighted-average grant date fair value per share, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant date fair value per share, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Plan Name [Domain] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Shareholders’ Equity - Schedule of Share Option Plan (Details) [Table] Options [Member] Equity Option [Member] Number of options, Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Schedule of Status of Option (Details) [Abstract] Weighted average remaining contractual life (years), Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average exercise price, Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average remaining contractual life (years), Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted-average grant date fair value per share, Beginning balance Weighted-average grant date fair value per share, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted-average grant date fair value per share, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Schedule of Expenses (Income), Net [Abstract] Foreign currency translation loss Foreign Currency Transaction Loss, before Tax Others Financial Expenses Others Represents the amount of financial expenses classified as others. Total financial income Other Nonoperating Income Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Weighted-average shares used in computing net loss per ordinary share, diluted Weighted-average shares used in computing net loss per share, diluted (in Shares) Weighted Average Number of Shares Outstanding, Diluted Net loss per ordinary share, diluted Net loss per share, diluted (in Dollars per share) Earnings Per Share, Diluted Schedule Of Significant Expenses Abstract Segments [Axis] Schedule Of Total Equity Based Compensation Expense Abstract Property and equipment, net Property, Plant and Equipment, Net Total long-term assets Assets, Noncurrent CURRENT LIABILITIES: Liabilities, Current [Abstract] Other payables and accrued expenses Other Accounts Payable and Accrued Liabilities Total current liabilities Liabilities, Current Long-term loan Loans Payable, Noncurrent Operating lease liabilities Operating Lease, Liability, Noncurrent Total long-term liabilities Liabilities, Noncurrent COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Significant and other segment expenses: Segment Reporting Information, Profit (Loss) [Abstract] Clinical trials, subcontractors and materials, net Other Expenses Other segment items Segment Reporting, Other Segment Item, Amount Tax on income Income Tax Expense (Benefit) Restricted deposits Restricted Investments, Current Total current assets Assets, Current Award Type [Domain] Basic and Diluted Net Loss Per Share [Abstract] Document Information [Table] Entity Central Index Key Entity Central Index Key Document Fiscal Year Focus Document Fiscal Year Focus Amendment Flag Amendment Flag Document Fiscal Period Focus Document Fiscal Period Focus Segments [Domain] Financial expenses: Interest and Debt Expense [Abstract] Financial income: Investment Income, Nonoperating [Abstract] Schedule of Significant Expenses [Line Items] Salaries and related benefits, including SBC, net Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold Professional, legal and marketing expenses Professional and Contract Services Expense Financial expenses (income), net Financial expenses (income), net Financial expenses (income), net Nonoperating Income (Expense) Segment net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Information [Line Items] Document Type Document Type Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Current Fiscal Year End Date Current Fiscal Year End Date Ordinary shares of no-par value per share – Authorized: 362,116,800 shares as of December 31, 2025 and June 30, 2026; Issued and outstanding: 88,009,737 and 92,332,873 shares as of December 31, 2025 and June 30, 2026, respectively Common Stock, Value, Issued Accumulated deficit Retained Earnings (Accumulated Deficit) Total liabilities and shareholders’ equity Liabilities and Equity Statement of Financial Position [Abstract] Ordinary shares, authorized (in Shares) Common Stock, Shares Authorized Ordinary shares, outstanding (in Shares) Balances (in Shares) Balances (in Shares) Common Stock, Shares, Outstanding Income Statement [Abstract] Marketing expenses Marketing Expense Total operating loss Operating Income (Loss) Loss before taxes on income Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss per share, basic (in Dollars per share) Net loss per ordinary share, basic Earnings Per Share, Basic Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Class of Warrant or Right [Domain] Long-Term Loan [Abstract] WARRANTS LIABILITY Warrants Liability Disclosure Text Block Fair Value Measurements [Abstract] Schedule of Level 3 Fair Value Measurements [Line Items] Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items] Private Warrants [Member] Private Warrants Member Total warrant liability Warrants liability Beginning of period End of period Warrants and Rights Outstanding Schedule of Level3 Fair Value Measurements [Abstract] General (Details) [Table] Ownership [Domain] General [Line Items] Strategic Collaboration, Supply and Securities Purchase Agreements with Tolmar [Line Items] Cash, cash equivalents, short-term deposits and restricted deposits Cash, Cash Equivalents, and Short-Term Investments Cash flows from operating activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Significant Accounting Policies (Details) [Table] Public Warrants [Member] Public Warrants Member Significant Accounting Policies [Line Items] Letter of credit Letters of Credit Outstanding, Amount Bearing interest rate Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate Interest expenses Interest Expense, Long-Term Debt Warrants Liability (Details) [Table] Equity Component [Domain] Class of Warrant or Right [Axis] Warrants Liability [Line Items] Term of warrants Warrants and Rights Outstanding, Term Warrants exercised Class Of Warrant Or Right Exercise Of Warrants Represent the number of warrant exercised. Redemption period Redemption Period Redemption period. Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Increase in prepaid expenses and other receivables Increase (Decrease) in Prepaid Expense and Other Assets Decrease in trade payables Increase (Decrease) in Accounts Payable, Trade Increase in deferred tax liability Increase (Decrease) in Deferred Income Taxes Change in operating lease liabilities Increase (Decrease) in Operating Lease Liability Share-based compensation Share-Based Payment Arrangement, Noncash Expense Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Investment in short-term deposits Payments to Acquire Short-Term Investments Proceeds from issuance of Ordinary shares, net Gross proceeds from issuance of ordinary shares Proceeds from Issuance of Common Stock Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Supplemental disclosures of cash flow information: Supplemental Cash Flow Elements [Abstract] Supplemental disclosure of noncash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Purchases of property, plant and equipment in exchange for Ordinary shares Purchases Of Property Plant And Equipment In Exchange For Ordinary Shares Represent the amount of purchases of property, plant and equipment in exchange for ordinary shares. General [Abstract] SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Lease [Abstract] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment SHAREHOLDERS’ EQUITY Equity [Text Block] Financial Expenses (Income), Net [Abstract] Fair Value Hierarchy and NAV [Axis] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] LONG-TERM LOAN Long-Term Debt [Text Block] Warrants Liability [Abstract] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Trading days Fair Market Value Of Ordinary Shares Number Of Trading Days Considered Number of trading days considered for determination of Fair Market Value of shares. Prior written notice of redemption Prior Written Notice Of Redemption Prior written notice of redemption period. ​Schedule of Basic and Diluted Net Loss Per Ordinary Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Reporting Segment and Geographic Information [Abstract] Statement [Table] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Operating lease cost Operating Lease, Cost Total net lease costs Lease, Cost Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Schedule of Minimum Lease Payments [Abstract] Present value of lease liabilities Operating Lease, Liability Schedule Of Liabilities Measured At Fair Value On ARecurring Basis Abstract Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Schedule of Components of Operating Lease Cost [Abstract] Equity Components [Axis] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Accumulated deficit Retained Earnings [Member] Statement [Line Items] Exercise of options (in Shares) Number of options, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Vesting of RSUs (in Shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross REPORTING SEGMENT AND GEOGRAPHIC INFORMATION Segment Reporting Disclosure [Text Block] Unaudited consolidated financial statements: Unaudited Interim Consolidated Financial Statements Policy Text Block Disclosure of accounting policy for unaudited interim consolidated financial statements. Ordinary share warrants classification and measurement: Ordinary Share Warrants Classification And Measurement Policy Text Block Disclosure of accounting policy for ordinary share warrants classification and measurement. Recently issued accounting pronouncements not yet adopted: New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Level 3 Fair Value Measurements Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of Share Option Plan Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Total Equity-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Measurement Frequency [Axis] Description of CODM Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Number of trading days Number Of Trading Days Number of trading days. Price per warrant (in Dollars per share) Price Per Warrant Price per warrant. Schedule of Significant Expenses Schedule of Segment Reporting Information, by Segment [Table Text Block] Balances Balances Total shareholders’ equity Equity, Attributable to Parent Exercise of options Stock Issued During Period, Value, Stock Options Exercised Vesting of RSUs Stock Issued During Period, Value, Restricted Stock Award, Gross BASIC AND DILUTED NET LOSS PER SHARE Earnings Per Share [Text Block] Significant Accounting Policies [Abstract] Statement of Stockholders' Equity [Abstract] Use of estimates for the preparation of financial statements: Use of Estimates, Policy [Policy Text Block] Fair value of financial instruments: Fair Value of Financial Instruments, Policy [Policy Text Block] Schedule of Components of Operating Lease Cost Lease, Cost [Table Text Block] Schedule of Liabilities Measured at Fair Value on a Recurring Basis Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Changes in Fair Value of Level 3 Private Warrants Liability Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Shareholders’ Equity [Abstract] Schedule of RSUs Under the Plan Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of Financial Expenses (Income), Net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Strike Price Per Share Number of strike price per share. Trading Days of Notice of Redemption Trading Days of Notice of Redemption. Number of Reportable Segments Entity [Domain] Legal Entity [Axis] Agreement payments (in Dollars) Agreement Payments Amount of agreement payments. Additional term payment Additional Term Payment Amount of additional term payment. Agreements terms Agreements Terms During the period of agreements term. Future Sales of Developed Product [Member] Future Sales Of Developed Product Member BGN Technologies [Member] Bgn Technologies Member Althera [Member] Althera Member Cambridge University Hospitals Nhs Trust [Member] Cambridge University Hospitals Nhs Trust Member Weighted average exercise price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Purchase price of per share Shares Issued, Price Per Share Related and Nonrelated Parties [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Sale of Stock [Axis] Sale of Stock [Domain] Private Placement [Member] Aggregate intrinsic value, Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Number of options, Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate intrinsic value, Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Number of options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Weighted average exercise price, Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Number of shares issued for services Stock Issued During Period, Shares, Issued for Services Unrecognized compensation costs Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Plan Name [Axis] Voting rights Common Stock, Voting Rights Number of options, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Shareholders’ Equity - Schedule of RSUs Under the Plan (Details) [Table] RSUs [Member] Restricted Stock Units (RSUs) [Member] Number of RSUs Unvested, Beginning balance Number of RSUs Unvested, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of RSUs, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of shares available for grant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Expiry period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Weighted average period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Issuance of shares Issuance of Ordinary shares (in Shares) Stock Issued During Period, Shares, New Issues Net proceeds received Issuance of Ordinary shares Stock Issued During Period, Value, New Issues Related and Nonrelated Parties [Axis] Common stock, par value Common Stock, Par or Stated Value Per Share Proceeds from issuance of private placement Proceeds from Issuance of Private Placement Common Stock, Shares, Issued Ordinary shares, issued (in Shares) Number of RSUs, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Location, Statement of Income, Balances [Axis] Location, Statement of Income, Balances [Domain] Research and development [Member] Research and Development Expenses [Member] Marketing expenses [Member] Selling and Marketing Expenses [Member] General and administrative [Member] General and Administrative Expenses [Member] Schedule of RSUs Under the Plan [Line Items] Weighted-average shares used in computing net loss per share, basic (in Shares) Weighted-average shares used in computing net loss per ordinary share, basic Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Number of RSUs, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Long-term prepaid expenses Prepaid Expense, Noncurrent Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Total assets Assets Trade payables Accounts Payable, Trade, Current Current maturities of operating lease liabilities Operating Lease, Liability, Current LONG-TERM LIABILITIES: Liabilities, Noncurrent [Abstract] Deferred tax liability Deferred Tax Liabilities, Gross Total liabilities Liabilities SHAREHOLDERS’ EQUITY: Equity, Attributable to Parent [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Ordinary shares of par value (in Dollars per share) Common Stock, No Par Value Research and development, net Research and Development Expense General and administrative General and Administrative Expense Additional paid-in capital Additional Paid-in Capital [Member] Share-based compensation APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Cash and cash equivalents Cash and Cash Equivalent Deferred revenue Contract with Customer, Liability, Noncurrent Schedule of Total Equity-Based Compensation Expense [Line Items] Interest on loan Interest Expense, Nonoperating Remeasurement of warrants Remeasurement Of Warrant Represent the value of remeasurement of warrants. Total financial expenses Other Nonoperating Expense Interest from deposits Interest Income, Deposits with Financial Institutions ​Schedule of Basic and Diluted Net Loss Per Ordinary Share [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Other Operating Segment [Member] Other Operating Segment [Member] CURRENT ASSETS: Assets, Current [Abstract] Short-term deposits Short-Term Investments Prepaid expenses and other receivables Prepaid Expense and Other Assets, Current LONG-TERM ASSETS: Assets, Noncurrent [Abstract] Variable lease cost Variable Lease, Cost Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details) [Table] Fair Value, Recurring [Member] Fair Value, Recurring [Member] 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Number of operating segments Number of Operating Segments Unconstrained milestone payment Unconstrained Milestone Payment The amount of total nominal or expected value of the milestone payment written in the contract before evaluating risk. COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Contingencies Disclosure [Text Block] FINANCIAL EXPENSES (INCOME), NET Other Income and Other Expense Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Increase in deferred revenue Increase (Decrease) in Contract with Customer, Liability Investment in restricted deposits Payment to Acquire Restricted Deposits The cash outflow associated with the restricted deposits. Operating lease liabilities arising from obtaining right of use assets Right-of-Use Asset Obtained in Exchange for Operating Lease Liability GENERAL Nature of Operations [Text Block] LEASE Lessee, Operating Leases [Text Block] Measurement Frequency [Domain] Strategic Collaboration, Supply and Securities Purchase Agreements with Tolmar [Abstract] STRATEGIC COLLABORATION, SUPPLY AND SECURITIES PURCHASE AGREEMENTS WITH TOLMAR Collaborative Arrangement Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Tolmar Agreements [Member] Milestone payment Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Payment for manufacturing Payment for Other Operating Activity Customer non-refund payments Customer Nonrefundable Fees, Nonrefund Payments Amount of cash outflow to customers for nonrefund payments. Excess over fair value paid Equity, Fair Value Adjustment Contract liability Contract with Customer, Liability Percentage of net sales of the product adjustments Concentration Risk, Percentage Term of commercial sale of the product agreement Initial Term of Commercial Sale and Product Agreements Term of commercial sale of the product agreement. Concentration Risk Benchmark [Axis] Ownership [Axis] ATM KK [Member] ATMKKJapan Tokyo Member Ownership percentage Subsidiary, Ownership Percentage, Parent Long-term loan Long-Term Debt Bank prime rate Line of Credit Facility, Interest Rate at Period End Currency exchange income Long Term Debt Currency Exchange Income Long Term Debt Currency Exchange Income. Closing price of ordinary shares per share (in Dollars per share) Closing Price Of Ordinary Shares Per Share Closing price of ordinary shares per share. 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three 2031 and thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Statement of Cash Flows [Abstract] Increase in long-term prepaid expenses Increase (Decrease) in Prepaid Expenses, Other Increase (decrease) in other payables and accrued expenses Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Depreciation Depreciation Non-cash financial expense (income), net Other Noncash Income (Expense) Change in the fair value of warrants liability Increase Decrease In Warrants Liability Represent the amount of change in the fair value of warrants liability. Change in operating lease right-of-use assets Increase (Decrease) in Other Operating Assets and Liabilities, Net Proceeds from exercise of options Proceeds from Stock Options Exercised Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Proceeds from short-term deposits Proceeds from Sale, Maturity and Collection of Short-Term Investments Increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash paid during the period for income tax Income Taxes Paid Cash paid during the period for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Concentration Risk Benchmark [Domain] Revenue Benchmark [Member] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Product Concentration Risk [Member] Supplier [Axis] Supplier [Domain] Tolmar [Member] Revenue recognized Contract with Customer, Liability, Revenue Recognized Estimated the transaction price Revenue, Remaining Performance Obligation, Amount Tranche [Axis] Tranche [Domain] One Clinical [Member] Capital resources minimum expected liquidity term Capital Resources Minimum Expected Liquidity Term Capital resources minimum expected liquidity term. Payment for issuance of equity securities Payments for Repurchase of Equity, Total Change in fair value Fair Value, Option, Changes in Fair Value, Gain (Loss) Expected term (years) [Member] Measurement Input, Expected Term [Member] Risk-free interest rate {Member] Measurement Input, Risk Free Interest Rate [Member] Fair value of Ordinary share [Member] Measurement Input, Share Price [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Measurement Input Type [Axis] Expected volatility [Member] Measurement Input, Price Volatility [Member] Expected dividend yield [Member] Measurement Input, Expected Dividend Rate [Member] Exercise price [Member] Measurement Input, Exercise Price [Member] Fair value measurements Warrants and Rights Outstanding, Measurement Input Schedule Of Changes In Fair Value Of Level3 Private Warrants Liability Abstract Fair Value Measurement Inputs and Valuation Techniques [Table] Schedule of Changes in Fair Value of Level 3 Private Warrants Liability [Line Items] Measurement Input Type [Domain] Chief Executive Officer